Home Sun Care FDA Points Boxed Warning For Osteoporosis Drug Prolia

FDA Points Boxed Warning For Osteoporosis Drug Prolia

0
FDA Points Boxed Warning For Osteoporosis Drug Prolia

[ad_1]

The U.S. Meals and Drug Administration (FDA) has issued a black field warning — reserved for essentially the most severe issues of safety — for the osteoporosis drug denosumab, bought underneath the model identify Prolia.

Sufferers with superior power kidney illness run the danger of extreme hypocalcemia — dangerously low blood calcium ranges that may trigger life-threatening unintended effects like seizures and coronary heart failure — once they take denosumab, the FDA mentioned in a January 19 assertion.

“For sufferers with superior kidney illness, particularly these on dialysis handled with Prolia, frequent monitoring of calcium within the blood, particularly for the primary 2 to 10 weeks after every Prolia injection, is beneficial,” the FDA mentioned within the assertion.

Signs that may point out extreme hypocalcemia embody confusion, seizures, fainting, face twitching, uncontrollable muscle spasms, tingling or numbness in components of the physique, or an irregular coronary heart rhythm, in line with the FDA. Folks taking denosumab who expertise these signs ought to contact their healthcare supplier — particularly if they’ve power kidney illness or are on dialysis, the FDA mentioned.

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here